Fifth Third Bancorp Myriad Genetics Inc Transaction History

Fifth Third Bancorp

$28.3 Billion
Q2 2025

A detailed history of Fifth Third Bancorp transactions in Myriad Genetics Inc stock. As of the latest transaction made, Fifth Third Bancorp holds 2,267 shares of MYGN stock, worth $10,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,267

Previous 46,489 95.12%

Holding current value

$10,541

Previous $412,000 97.09%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$3.84 - $8.84 $169,812 - $390,922	-44,222 Reduced 95.12%	2,267 $12,000
Q1 2025 Apr 15, 2025	SELL	$8.87 - $14.98 $78,286 - $132,213	-8,826 Reduced 15.96%	46,489 $412,000
Q4 2024 Jan 21, 2025	SELL	$13.17 - $27.03 $306,808 - $629,690	-23,296 Reduced 29.63%	55,315 $758,000
Q3 2024 Oct 17, 2024	SELL	$23.97 - $28.6 $75,337 - $89,889	-3,143 Reduced 3.84%	78,611 $2.15 Million
Q2 2024 Jul 22, 2024	BUY	$17.98 - $25.47 $20,479 - $29,010	1,139 Added 1.41%	81,754 $2 Million
Q1 2024 Apr 23, 2024	BUY	$17.59 - $23.59 $49,463 - $66,335	2,812 Added 3.61%	80,615 $1.72 Million
Q4 2023 Jan 19, 2024	BUY	$13.91 - $21.32 $51,397 - $78,777	3,695 Added 4.99%	77,803 $1.49 Million
Q3 2023 Oct 31, 2023	SELL	$15.99 - $23.22 $6,172 - $8,962	-386 Reduced 0.52%	74,108 $1.19 Million
Q2 2023 Jul 25, 2023	BUY	$17.56 - $23.76 $93,489 - $126,498	5,324 Added 7.7%	74,494 $1.73 Million
Q1 2023 Apr 24, 2023	BUY	$15.26 - $23.75 $43,262 - $67,331	2,835 Added 4.27%	69,170 $1.61 Million
Q4 2022 Jan 25, 2023	BUY	$14.51 - $20.99 $113,685 - $164,456	7,835 Added 13.39%	66,335 $0
Q3 2022 Oct 25, 2022	BUY	$18.21 - $27.88 $610,745 - $935,067	33,539 Added 134.37%	58,500 $1.12 Million
Q2 2022 Aug 04, 2022	BUY	$16.45 - $25.88 $51,685 - $81,314	3,142 Added 14.4%	24,961 $454,000
Q1 2022 Apr 19, 2022	BUY	$22.67 - $28.01 $108,702 - $134,307	4,795 Added 28.17%	21,819 $550,000
Q4 2021 Feb 01, 2022	BUY	$24.13 - $32.63 $73,741 - $99,717	3,056 Added 21.88%	17,024 $470,000
Q3 2021 Oct 15, 2021	BUY	$29.97 - $36.66 $87,182 - $106,643	2,909 Added 26.3%	13,968 $451,000
Q2 2021 Aug 06, 2021	SELL	$25.39 - $32.61 $39,481 - $50,708	-1,555 Reduced 12.33%	11,059 $338,000
Q1 2021 May 07, 2021	BUY	$19.92 - $31.6 $19,661 - $31,189	987 Added 8.49%	12,614 $384,000
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $52,312 - $85,050	4,302 Added 58.73%	11,627 $230,000
Q3 2020 Nov 09, 2020	BUY	$11.25 - $14.75 $3,318 - $4,351	295 Added 4.2%	7,325 $96,000
Q2 2020 Aug 05, 2020	BUY	$10.69 - $16.49 $39,713 - $61,260	3,715 Added 112.07%	7,030 $80,000
Q1 2020 May 05, 2020	BUY	$9.78 - $29.53 $32,420 - $97,891	3,315 New	3,315 $47,000

Others Institutions Holding MYGN

# of Institutions

242

Shares Held

96M

Call Options Held

95.4K

Put Options Held

18.2K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $375M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Myriad Genetics Inc Transaction History